A Phase 2, Multicenter Open-Label Extension (OLE) Study With ABT-122 in Active Psoriatic Arthritis Subjects Who Have Completed a Preceding Study M14-197

Clinical trial NCT02429895 · TERMINATED

Trial details

NCT number: NCT02429895
Sponsor: AbbVie
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Psoriatic Arthritis

Start date: 2015-10-01
Primary completion: 2016-05-01
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.